Aim of the project. costs/expenditure, output, productivity, health outcomes, 1 The main aim of this project is to provide a quantitative analysis on:
|
|
- Rodger Potter
- 5 years ago
- Views:
Transcription
1
2 Aim of the project 1 The main aim of this project is to provide a quantitative analysis on: costs/expenditure, output, productivity, health outcomes, of the Italian health care system based on patient level data by means of a microsimulation model using data collected by individual Italian GPs.
3 The Health Search database in figures patients in the DB; diagnoses/problems; lab tests and diagnostic tests; blood pressure measurements; drug prescriptions. 6 Data available from year 2000 in form of an unbalanced panel
4 Health Search DB: Quality of the data Accuracy: % of coded diagnoses, % of prescriptions linked to diagnoses Completeness: % of data on prevention (i.e. smoking, BMI, cholesterol, Blood Pressure) Frequency of recording: N recorded daily visits visits standardized by No. of total patients
5 Health Search DB: National representativeness - 1 The distribution of patients by age in HSD is very close to the distribution by age recorded by ISTAT (ONS)
6 Health Search DB: National representativeness - 2 Prevalence of chronic pathologies: HSD vs ISTAT (HIS)
7 Health Search DB: National representativeness - 3 DDD/1000 habitant die per each therapeutic group over total DDD/1000 habitant die: HEALTH SEARCH vs OsMed.
8 Prices and Tariffs 1 We have completed the raw information included in the HS dataset with the following data: Drug prices; Lab and diagnostic test tariffs (at regional level); Hospital DRG tariffs (at regional level); GP salary.
9 SiSSI - Italian Simulation Model of Health Expenditure Building up the model 1 Phase 1 - Static model Static analysis of outcomes, output, costs and utilization in the NHS; Total costs (by region, patient, GP, pathology, etc.); Benchmarking across regions, GPs, patients, etc.; Analysis of alternative health policies ("what if"). 2 Phase 2 - Dynamic model Analysis of chronic diseases and the effect that medical treatments have on them; Analysis of health expenditure in the medium-long run; Analysis of financial sustainability of the system.
10 The expected results of the model 1 As all our information are at patient level and over time, we can construct: Price and Quantity Indices; Cost of Treatment Indices; Health Outcomes Indices; Cost-Effectiveness Indices ( health/ inputs) Treatment effect (on treated) indices. 2 All these measures can be produced by good and services, groups of patients, GPs, gender, age, region, disease,...and any possible combination of all characteristics we have in the dataset. 3 Unfortunately we cannot observe patients income and education. However we do have information regarding income exemption status.
11 SiSSI model: Preliminary results - 1 Structure of output
12 SiSSI model: Preliminary results - 2 Total cost of treatment (drugs and diagnostic tests), by gender
13 SiSSI model: Preliminary results - 3 Total cost of treatment (drugs and diagnostic tests), by gender with Confidence Intervals- 2008
14 SiSSI model: Preliminary results - 4 Total cost of treatment (drugs and diagnostic tests), by geographic area
15 SiSSI model: Preliminary results - 5 Total cost of treatment (drugs and diagnostic tests), by geographic area with Confidence Intervals- 2008
16 SiSSI model: Preliminary results - 6 Total cost of treatment (drugs and diagnostic tests), by year
17 SiSSI model: Preliminary results - 7 Total cost of treatment (drugs and diagnostic tests), by year with Confidence Intervals
18 SiSSI model: Preliminary results - 8 Average drug price and ddd price by quarter and year
19 SiSSI model: Preliminary results - 9 Average diagnostic test price by quarter and year
20 SiSSI model: Preliminary results - 10 Average drug prescriptions (ddd) by quarter and year
21 SiSSI model: Preliminary results - 11 Average diagnostic test prescriptions by quarter and year
22 SiSSI model: Preliminary results - 12 Price and Quantity Indices In order to compare over time drug and diagnostic test prescriptions and prices, we used several types of indices, such as Laspeyres price and quantity indices (fixed-base and fixed-weight): P0,t L = n p i,t i=1 p p i,0 i,0 q i,0 n i=1 p i,0 q i,0 Q0,t L = n q i,t i=1 q p i,0 i,0 q i,0 n i=1 p i,0 q i,0 Paasche price and quantity indices (fixed-base and variable-weight): P0,t P = n i=1 p i,t q i,t n p i,t q i,t i=1 p i,t /p i,0 Q0,t P = n i=1 p i,t q i,t n p i,t q i,t i=1 q i,t /q i,0 and Fisher price and quantity indices, the geometric mean of Laspeyres and Paasche indices. Furthermore, we used the following synthetic indices (a cost index and a quantity index): I C 0,t = n i=1 p i,t q i,t n i=1 p i,0 q i,t I Q 0,t = n i=1 q i,t n i=1 q i,0
23 SiSSI model: Preliminary results - 13 With the aim of approximating the impact of technological progress, we produced the following three indices: 1) A cost index with fixed-basket and fixed-quantities. I C1 0,t = n i=1 p i,t q i,0 n i=1 p i,0q i,0 2) A cost index with fixed-basket and variable-quantities. I C2 0,t = n i=1 p i,t q i,t n i=1 p i,0q i,0 3) A cost index with variable-basket and variable-quantities. I C3 0,t = n i=1 p i,t Q i,t n i=1 p i,0q i,0
24 SiSSI model: Preliminary results - 14 Cost indices for drugs and diagnostic tests and their subcategories INDICI DI COSTO Farmaci Farmaci: A* Farmaci: B* Farmaci: C* Farmaci: D* Farmaci: G* Farmaci: H* Farmaci: J* Farmaci: L* Farmaci: M* Farmaci: N* Farmaci: P* Farmaci: R* Farmaci: S* Farmaci: V* Farmaci: Statine (ATC=C10AA) Farmaci: Fans (ATC=M01A) Test Test: Nord-Occidente Test: Nord-Oriente Test: Centro Test: Sud Test: Isole Test: Ferritina Test: Colesterolo LDL Test: Creatinina Colesterolo Diabete *A: Tratto alimentare e metabolismo B: Sangue e organi eritropoietici C: Apparato cardiovascolare D: Farmaci dermatologici G: Apparato genito-urinario e ormoni sessuali H: Preparazioni ormonali sistemiche, esclusi ormoni sessuali e insulina J: Anti-infettivi per uso sistemico L: Antineoplastici e immunomodulatori M: Apparato muscolo-scheletrico N: Sistema nervoso P: Prodotti antiparassitari, insetticidi e repellenti R: Apparato respiratorio S: Organi sensori V: Vari
25 SiSSI model: Preliminary results - 15 Quantity indices for drugs and diagnostic tests and their subcategories INDICI DI QUANTITA Farmaci Farmaci: A* Farmaci: B* Farmaci: C* Farmaci: D* Farmaci: G* Farmaci: H* Farmaci: J* Farmaci: L* Farmaci: M* Farmaci: N* Farmaci: P* Farmaci: R* Farmaci: S* Farmaci: V* Farmaci: Statine (ATC=C10AA) Farmaci: Fans (ATC=M01A) Test Test: Nord-Occidente Test: Nord-Oriente Test: Centro Test: Sud Test: Isole Test: Ferritina Test: Colesterolo LDL Test: Creatinina *A: Tratto alimentare e metabolismo B: Sangue e organi eritropoietici C: Apparato cardiovascolare D: Farmaci dermatologici G: Apparato genito-urinario e ormoni sessuali H: Preparazioni ormonali sistemiche, esclusi ormoni sessuali e insulina J: Anti-infettivi per uso sistemico L: Antineoplastici e immunomodulatori M: Apparato muscolo-scheletrico N: Sistema nervoso P: Prodotti antiparassitari, insetticidi e repellenti R: Apparato respiratorio S: Organi sensori V: Vari
26 SiSSI model: Preliminary results - 16 Cost indices: Statins
27 SiSSI model: Preliminary results - 17 Cost indices: FANS
28 SiSSI model: Preliminary results - 18 Analysis by Disease: Hypercholesterolemia and Diabetes
29 SiSSI model: Preliminary results - 19 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by gender
30 SiSSI model: Preliminary results - 20 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by gender and cohort size
31 SiSSI model: Preliminary results - 21 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by cohort size and year
32 SiSSI model: Preliminary results - 22 Total cost of Hypercholesterolemia treatment, for pathology and comorbidities
33 SiSSI model: Preliminary results - 23 Total cost of Hypercholesterolemia treatment, for pathology and comorbidities with Confidence Intervals- 2008
34 SiSSI model: Preliminary results - 24 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by geographic area
35 SiSSI model: Preliminary results - 25 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by geographic area - Average
36 SiSSI model: Preliminary results - 26 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by year
37 SiSSI model: Preliminary results - 27 Total cost of treatment for patient with Hypercholesterolemia (including all comorbidities), by year with Confidence Intervals
38 SiSSI model: Preliminary results - 28 Total cost of treatment for patient with Diabetes (including all comorbidities), by gender
39 SiSSI model: Preliminary results - 29 Total cost of treatment for patient with Diabetes (including all comorbidities), by gender and cohort size
40 SiSSI model: Preliminary results - 30 Total cost of treatment for patient with Diabetes (including all comorbidities), by cohort size and year
41 SiSSI model: Preliminary results - 31 Total cost of Diabetes treatment, for pathology and comorbidities
42 SiSSI model: Preliminary results - 32 Total cost of Diabetes treatment, for pathology and comorbidities with Confidence Intervals- 2008
43 SiSSI model: Preliminary results - 33 Total cost of treatment for patient with Diabetes (including all comorbidities), by geographic area
44 SiSSI model: Preliminary results - 34 Total cost of treatment for patient with Diabetes (including all comorbidities), by geographic area - Average
45 SiSSI model: Preliminary results - 35 Total cost of treatment for patient with Diabetes (including all comorbidities), by year
46 SiSSI model: Preliminary results - 36 Total cost of treatment for patient with Diabetes (including all comorbidities), by year with Confidence Intervals
47 SiSSI model: Preliminary results - 37 Delay in disease occurrences
48 SiSSI model: Preliminary results - 38 Number of patients by age and year - Arthrosis
49 SiSSI model: Preliminary results - 39 Number of patients by age and year - Arthritis
50 SiSSI model: Preliminary results - 40 Number of patients by age and year - Hypercholesterolemia
51 SiSSI model: Preliminary results - 41 Number of patients by age and year - Diabetes
52 SiSSI model: Preliminary results - 42 Distributional aspects of treatment costs Skewness is substantial Is the average so informative?
53 SiSSI model: Preliminary results - 43 Treatment cost by quantile and age - Arthrosis
54 SiSSI model: Preliminary results - 44 Treatment cost by quantile and age - Arthritis
55 SiSSI model: Preliminary results - 45 Treatment cost by quantile and age - Asthma
56 SiSSI model: Preliminary results - 46 Treatment cost by quantile and age - Hypercholesterolemia
57 SiSSI model: Preliminary results - 47 Treatment cost by quantile and age - Diabetes
58 SiSSI model: Preliminary results - 48 VERY, VERY PRELIMINARY RESULTS!!!!
59 SiSSI model: Preliminary results - 49 Drug treatment and diagnostic test costs by age, gender and region Regione Femmine Maschi Abruzzo Basilicata Calabria Campania Emilia-Romagna Friuli-Venezia Giulia Lazio Liguria Lombardia Marche Piemonte Puglia Sardegna Sicilia Toscana Trentino-Alto Adige Umbria Veneto
60 SiSSI model: Preliminary results - 50 Drug treatment and diagnostic test costs by gender and region
61 SiSSI model: Preliminary results - 51 Drug treatment and diagnostic test costs by age, gender and type of region Regione Femmine Maschi Piano di rientro Con piano di rientro Senza piano di rientro Piano di rientro (escluse Sardegna e Liguria) Con piano di rientro Senza piano di rientro
62 SiSSI model: Preliminary results - 52 An example of health outcome index: Trends of Total and LDL Cholesterol by year
63 SiSSI model: Preliminary results - 53 An example of health outcome index: Trends of LDL Cholesterol by geographic area
64 SiSSI model: Preliminary results - 54 An example of health outcome index: Distribution of LDL Cholesterol by year
65 Conclusions and future agenda 1 HS represents an important source of information for output and productivity analysis as it is based on GP and patient microdata. 2 The potential number of GPs enrolled in this project can be easily extended to more than 5.000! This will imply extending our sample to more than 14 millions of patients! 3 More important, the quality, richness and completeness of the information collected could be easily improved over time. 4 The agenda for the future: Include information on non-treated patients Construct weights for inference to the whole population
PDTA: assistential and diagnostic-therapeutic paths
PDTA: assistential and diagnostic-therapeutic paths Salvatore Leone Amici Onlus, National Coalition of Associations for Patients suffering Chronic Diseases (CnAMC), Italy What is IBD? Crohn s disease and
More informationThe Italian decision to mandate. children vaccinations. Fortunato D Ancona, MD Italian Ministry of Health
The Italian decision to mandate children vaccinations Fortunato D Ancona, MD Italian Ministry of Health The ASSET FINAL EVENT Share and move for mobilization and mutual learning at local, national and
More informationSpecial Olympics Family Leadership and Support. Family Program Example Special Olympics Italy
Special Olympics Family Leadership and Support Family Program Example Special Olympics Italy Special Olympics vision The new strategic plan Families are asked to become COMMUNITY BUILDERS National Organizing
More informationScreening di Popolazione. del Cancro Colorettale. C. Hassan
Screening di Popolazione del Cancro Colorettale C. Hassan The Present 1. Organized screening program - Active invitation (less inequality) - Rapid coverage of the target population (2 yrs) - Quality Assurance
More informationPrEPararsi alla PrEP: indagine sulla propensione dei medici di malattie infettive
UOC Infezioni emergenti e Centro di riferimento AIDS Dipartimento di Epidemiologia Istituto Nazionale per le Malattie Infettive L. Spallanzani - IRCCS, Rome, Italy Profilassi con antiretrovirali pre- e
More informationStatistical Table 20: Prevalence of antibodies against hepatitis B virus among injecting drug users in the EU (sample sizes in brackets)
Belgium, French Community 23.5 (5 23.8 (240 20.0 (95 5.7 (27 SR selfreported test results; > 80% missing data. Belgium, Flemish Community 7.9 (06 20.0 (55 2.7 (57 5.0 (33 7. (3 AHBs. Drug, 2 Belgium, Flemish
More informationA standardization study of the Italian version of Frenchay Aphasia Screening Test in aphasic patients and control subjects
9 th European Congress of Speech and Language Therapy Palazzo dei Congressi & Palazzo degli Affari, Florence, Italy 8/9 May 2015 A standardization study of the Italian version of Frenchay Aphasia Screening
More informationABRCAdaBRA:Opening the Way to Women with a BRCA Mutation in Italy. Ornella Campanella February 5, 2016
ABRCAdaBRA:Opening the Way to Women with a BRCA Mutation in Italy Ornella Campanella February 5, 2016 Who we are? Everythings was born on Facebook two years ago. Then we met in Pavia during the 4 Pavia
More informationItalian Observatory on Healthcare Report 2014 Health status and quality of care in the Italian Regions
Italian Observatory on Healthcare Report 2014 Health status and quality of care in the Italian Regions Summary by Dr. Alessandro Solipaca e Dr. Marta Marino Osservasalute Report 2013 Summary Since 12 years,
More informationL USO DELLA RISORSA ALBUMINA LA PROSPETTIVA DEL CLINICO
AISF-SIMTI POSITION PAPER - L USO APPROPRIATO DELL ALBUMINA Roma, 29 marzo 2016 L USO DELLA RISORSA ALBUMINA LA PROSPETTIVA DEL CLINICO Mauro Bernardi Semeiotica Medica Dipartimento di Scienze Mediche
More information2nd International Expert Meeting on Gluten Sensitivity Munich, December 1st 2012
2nd International Expert Meeting on Gluten Sensitivity Munich, December 1st 2012 NON CELIAC GLUTEN SENSITIVITY IN ADULTS: CLINICAL AND SEROLOGICAL ASPECTS Umberto Volta Coeliac Disease and Malabsorption
More informationPriority actions of the different Regional Prevention Plans: common features and innovations
Priority actions of the different Regional Prevention Plans: common features and innovations Francesca Russo (1), Federica Michieletto (1), Annarosa Pettenò (1), Chiara Postiglione (2), Giuseppina Napoletano
More informationPAIN makes a difference
PAIN makes a difference 1 yester day. large problem small solutions 2 not just compassion. 3 opioid consumption 2006!0.35 National healthcare service per capita disbursement 4 opioid consumption 2007!0.67
More informationBLUETONGUE IN ITALY: RISK ANALYSIS ON THE INTRODUCTION INTO FREE TERRITORIES OF VAC- CINATED ANIMALS FROM RE- STRICTED ZONES.
BLUETONGUE IN ITALY: RISK ANALYSIS ON THE INTRODUCTION INTO FREE TERRITORIES OF VAC- CINATED ANIMALS FROM RE- STRICTED ZONES. Bruxelles, 3 Dicembre 2002 INTRODUCTION...1 Italian strategy against bluetongue...
More informationCONCLUSIONS (Random Thoughts and Take Home Questions) gianluigi casadei
CONCLUSIONS (Random Thoughts and Take Home Questions) gianluigi casadei IL SOLE 24 ORE (September 4, 2012) Sustainability of health spending is a known issue for a long time The current crisis has dramatized
More informationAn Italian survey on the attitudes in treating breakthrough cancer pain in hospice
Support Care Cancer (2011) 19:979 983 DOI 10.1007/s00520-010-0919-5 ORIGINAL ARTICLE An Italian survey on the attitudes in treating breakthrough cancer pain in hospice Sebastiano Mercadante & Patrizia
More informationINCREASING VACCINATION IN CHILDREN. Susanna Esposito
INCREASING VACCINATION IN CHILDREN Susanna Esposito Pediatric Highly Intensive Care Unit, University of Milan, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Milan, Italy DISCLOSURE OF INTEREST
More informationTemporal and regional trends of choking injuries in children in Italy,
Lorenzoni et al. Injury Epidemiology (2018) 5:30 https://doi.org/10.1186/s40621-018-0160-0 ORIGINAL CONTRIBUTION Open Access Temporal and regional trends of choking injuries in children in Italy, 2001
More informationPharmaco-economic aspects of in-vitro fertilization in Italy Mantovani L G, Belisari A, Szucs T D
Pharmaco-economic aspects of in-vitro fertilization in Italy Mantovani L G, Belisari A, Szucs T D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion
More informationMarina Davoli Department of Epidemiology Lazio Region/Italian National Agency for Regional Health Services
Marina Davoli Department of Epidemiology Lazio Region/Italian National Agency for Regional Health Services Main objectives of the PNE include: comparative evaluation among healthcare providers; comparative
More informationITALY New Development, Trends and in-depth information on selected issues
Focal Point Logo 2006 NATIONAL REPORT (2005 data) TO THE EMCDDA by the Reitox National Focal Point ITALY New Development, Trends and in-depth information on selected issues REITOX !"$ % &"!"'$(" ) $"$$(
More informationAn Italian experience of training teachers* under the School Fruit and Vegetables Scheme
An Italian experience of training teachers* under the School Fruit and Vegetables Scheme Laura Gennaro Research Centre for Food and Nutrition (CREA-AN) laura.gennaro@crea.gov.it *Project funded by the
More informationFocus on PD. Roberto Russo. Azienda Ospedaliera Policlinico di Bari
Focus on PD Roberto Russo Azienda Ospedaliera Policlinico di Bari Peritoneal Dialysis Access Our meta-analysis clearly demonstrates benefits for catheters with a straight intraperitoneal segment Kidney
More informationStatistical Table 17: Prevalence of hepatitis C infection among injecting drug users under age 25 in the EU (%) (sample sizes between brackets)
Belgium, French Community 99 992 993 994 995 996 997 998 999 2000 200 / 40.9 (22) 47.4 (38) 3.9 (38) 26.7 (5) SR centres; self-reported test results. > 80% missing data. Belgium, French Community - Charleroi
More informationStatistical Table 13: Prevalence of HIV infection (%) among injecting drug users under age 25, in the EU (sample sizes between brackets)
Statistical Table 3: Prevalence of HIV infection (%) among injecting drug users under, in the EU (sample sizes between brackets) HIV IDUs under Belgium, French Community 99 992 993 994 995 996 997 998
More informationGeographic and socio-economic variation of sodium and potassium intake in Italy. Results from the MINISAL-GIRCSI programme. For peer review only
Geographic and socio-economic variation of sodium and potassium intake in Italy. Results from the MINISAL-GIRCSI programme. Journal: Manuscript ID: bmjopen-0-00 Article Type: Research Date Submitted by
More informationWhat s the seismic risk perception in Italy?
What s the seismic risk perception in Italy? Crescimbene Massimo 1, La Longa Federica 1, Camassi Romano 2, Pino Nicola Alessandro 3, Peruzza Laura 4 1 INGV, Via di Vigna Murata 65, 143, Rome, Italy 2 INGV,
More informationA new method for estimating the illicit cigarette market at the subnational level and its application to Italy
This is an Accepted Manuscript of an article published in Global Crime on 21 February 2014, available online: http://www.tandfonline.com/ 10.1080/17440572.2014.882777 A new method for estimating the illicit
More informationMelanoma in the Italian Population and Regional Environmental Influences: A National Retrospective Survey on Hospitalization Records
Int. J. Environ. Res. Public Health 2015, 12, 9102-9118; doi:10.3390/ijerph120809102 OPEN ACCESS Article International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph
More informationClinical Research. The impact of economic crisis on mental and physical health in Italy
103 The impact of economic crisis on mental and physical health in Italy M. Ruggeri; S. Tomassi Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Italy
More informationPOSITION PAPER PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE
POSITION PAPER 1 PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE GROUP LEADER: Basilicata Region OTHER PARTNERS: Calabria; Campania; Lazio; Marche; Piemonte; Prov. Aut.
More informationThe Seismic Risk Perception Questionnaire Crescimbene M. 1, La Longa F. 1, Camassi R. 1, Pino N.A. 1.
The Seismic Risk Perception Questionnaire Crescimbene M. 1, La Longa F. 1, Camassi R. 1, Pino N.A. 1 1 Istituto Nazionale di Geofisica e Vulcanologia, Rome, Italy (massimo.crescimbene@ingv.it, +390651860808)
More informationBREEDING AND AGRONOMICAL TECHNIQUES TO PRODUCE MEDICAL CANNABIS
Universität Innsbruck Institut für Pharmazie/Pharmakognosie BREEDING AND AGRONOMICAL TECHNIQUES TO PRODUCE MEDICAL CANNABIS Gianpaolo Grassi CREA-CI, Rovigo s branch station 15 th of November 2018 (Vienna)
More informationUpdate of the universal vaccination programme in Italy
Update of the universal vaccination programme in Italy Progress in the prevention and control of hepatitis B in Italy, 12 years after the implementation of universal vaccination. Duration of immunity and
More informationProvided in Cooperation with: Institute for Social and Economic Research (ISER), University of Essex
econstor www.econstor.eu Der Open-Access-Publikationsserver der ZBW Leibniz-Informationszentrum Wirtschaft The Open Access Publication Server of the ZBW Leibniz Information Centre for Economics Rondinelli,
More informationData and CRF management: P. Vaghi (Saronno), P. Calisi (Arenzano - GE), C. Chiavetta (Genova), Aristea SpA (Genova), Segno & Forma SpA (Milano).
Monaldi Arch Chest Dis 2007; 68: 193-198 ISYDE 2008 ISYDE-2008 Study presentation The Italian SurveY on cardiac rehabilitation: a snapshot of current cardiac rehabilitation programmes and provides in Italy
More informationItalians and Alcohol: Consumption, Trend and Attitudes in Italy and in the Regions
Indagine DOXA IV Italians and Alcohol: Consumption, Trend and Attitudes in Italy and in the Regions IV National DOXA National Survey Index 1. Introduction 2. Consumers and non-consumers of alcoholic beverages:
More informationEuropean Innovation Partnership on Active and Healthy Ageing
European Innovation Partnership on Active and Healthy Ageing Jorge PINTO ANTUNES Deputy Head of Unit Innovation for Health DG SANCO, European Commission The challenge of an ageing global population the
More informationEuroTrak Italy Results
Results EuroTrak Italy 2015 1. Introduction 2. Market overview 3. Analysis of hearing aid owners 4. Analysis of hearing impaired non-owners 5. Appendix Research to create value Summary 1. Introduction
More informationCardiovascular Screening Program CARDIO 50
Cardiovascular Screening Program CARDIO 50 Dr. Francesca Russo, Dr. Mary Elizabeth Tamang, Dr. Federica Michieletto Direzione Prevenzione, Sicurezza Alimentare, Veterinaria Regione del Veneto 8 February
More informationThe impact of real practice inappropriateness and devices inefficiency to variability in growth hormone consumption
J Endocrinol Invest (2014) 37:979 990 DOI 10.1007/s40618-014-0138-x ORIGINAL ARTICLE The impact of real practice inappropriateness and devices inefficiency to variability in growth hormone consumption
More informationA National Quality Assurance program for breast immunohistochemistry: an Italian perspective
PATHOLOGICA 208;0:83-9 Original article A National Quality Assurance program for breast immunohistochemistry: an Italian perspective E. GUADAGNO, G. DE ROSA *, O. NAPPI 2 Department of Advanced Biomedical
More informationCase Study: Type 2 Diabetes Management Care Pathway
Care Pathways: Guidance on Appraising Sustainability Case Study: Type 2 Diabetes Management Care Pathway October 2015 Coalition for Sustainable Pharmaceuticals and Medical Devices (CSPM) www.sduhealth.org.uk/cspm
More informationEvaluation of care services provided to female patients by Drug Addiction Department: a national explorative survey
Journal of Applied Medical Sciences, vol. 2, no. 1, 2013, 11-23 ISSN: 2241-2328 (print version), 2241-2336 (online) Scienpress Ltd, 2013 Evaluation of care services provided to female patients by Drug
More informationLevothyroxine and lung cancer in females: the importance of oxidative stress
Cornelli et al. Reproductive Biology and Endocrinology 2013, 11:75 RESEARCH Open Access Levothyroxine and lung cancer in females: the importance of oxidative stress Umberto Cornelli 1, Gianni Belcaro 2,
More informationDepartment of Political Science. Bachelor in Politics, Philosophy and Economics. Chair of Statistics
Department of Political Science Bachelor in Politics, Philosophy and Economics Chair of Statistics What about Italy abroad? A statistical analysis about Il Bel Paese among young international people Supervisor
More informationThe Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study
PharmacoEconomics Open https://doi.org/10.1007/s41669-017-0062-z ORIGINAL RESEARCH ARTICLE The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study Claudio
More informationAMORAL FAMILISM, SOCIAL CAPITAL, OR TRUST? THE BEHAVIOURAL FOUNDATIONS OF THE ITALIAN NORTH SOUTH DIVIDE*
The Economic Journal, 126 (August), 1318 1341. Doi: 10.1111/ecoj.12292 Published by John Wiley & Sons, 9600 Garsington Road, Oxford OX4 2DQ, UK and 350 Main Street, Malden, MA 02148, USA. AMORAL FAMILISM,
More informationEIP AHA Valencia 2016 Towards an Active and Healthy Ageing. Emilia-Romagna Region - Reference Site EIP-AHA
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing Emilia-Romagna Region - Reference Site EIP-AHA A Regional Model to Predict Identify and Manage Multimorbidity and Frailty Mirca Barbolini Valencia
More informationTables 1-6 show a summary of main results related on screen detected cases during (age 50-69). Table 7 shows time trends
Audit system on Quality of breast cancer diagnosis and Treatment (QT): results from the survey on screen-detected lesions in Italy, Antonio Ponti, Maria Piera Mano, Vito Distante, Rita Bordon, Luigi Cataliotti,
More informationCONFERENCE THE NEW GUARANTEE SYSTEM AND THE INTEGRATED CARE PATHWAYS (ICP) EVALUATION March 2018 Turin, C.so Regina Margherita, 174
CONFERENCE Integrated services: organizational healthcare models in the framework of chronic diseases. THE NEW GUARANTEE SYSTEM AND THE INTEGRATED CARE PATHWAYS (ICP) EVALUATION 26-27 March 2018 Turin,
More informationMESOTHELIOMA MORTALITY SURVEILLANCE IN ITALY
MESOTHELIOMA MORTALITY SURVEILLANCE IN ITALY Lucia Fazzo, Pietro Comba Dipartimento di Ambiente e Connessa Prevenzione Primaria. Istituto Superiore di Sanità, Rome Introduction The objective of the present
More informationextraction can take place. Another problem is that the treatment for chronic diseases is sequential based upon the progression of the disease.
ix Preface The purpose of this text is to show how the investigation of healthcare databases can be used to examine physician decisions to develop evidence-based treatment guidelines that optimize patient
More informationA SPATIAL MICROSIMULATION MODEL OF CO-MORBIDITY: FIRST RESULTS. Dr Karyn Morrissey, Dr Ferran Espuny, Dr Paul Williamson.
A SPATIAL MICROSIMULATION MODEL OF CO-MORBIDITY: FIRST RESULTS Dr Karyn Morrissey, Dr Ferran Espuny, Dr Paul Williamson. Rationale for Modelling using Microdata Much modelling in the social sciences takes
More informationFourth Report Better data quality. Addendum BETTER DATA QUALITY. Italian Arthroplasty Registry Project. English version of Tables and Figures
ITALIAN ARTHROPLASTY REGISTRY PROJECT Fourth Report 2017 Italian Arthroplasty Registry Project Better data quality BETTER DATA QUALITY for FOR better BETTER PATIENT patient SAFETY safety Fourth Report
More informationImpact of HPV vaccination: health gains in the Italian female population
Marcellusi Population Health Metrics (2017) 15:36 DOI 10.1186/s12963-017-0154-0 RESEARCH Impact of HPV vaccination: health gains in the Italian female population Andrea Marcellusi 1,2,3 Open Access Abstract
More informationRhynchophorus ferrugineus in Europe survey results Nándor Pete
Food and Veterinary Office Rhynchophorus ferrugineus in Europe survey results Nándor Pete Topics General situation in the EU Specific situation of the Member States Interceptions Conclusions R. ferrugineus
More informationCommercial Health Insurance Claims Data. for Studying HIV/AIDS Care. Senior Scientist, Innovus Epidemiology. David D.
Commercial Health Insurance Claims Data for Studying HIV/AIDS Care David D. Dore, PharmD, PhD Senior Scientist, Innovus Epidemiology Adjunct Assistant Professor, Alpert Medical School, Brown University
More informationRadiation exposure of the Italian population from diagnostic radiology and nuclear medicine examinations
Workshop on European Population Doses from Medical Exposure 24-26 April 2012, Athens, Greece Radiation exposure of the Italian population from diagnostic radiology and nuclear medicine examinations Gaetano
More informationBEENET: ITALIAN BEEKEEPING MONITORING NETWORK PRELIMINARY DATA
BEENET: ITALIAN BEEKEEPING MONITORING NETWORK PRELIMINARY DATA Porrini C 1, Lodesani M 2, Libertà A 3, Bortolotti L 2, Gallina A 4, Colombo R 2, Sgolastra F 1, Medrzycki P 2, Bozza MA 4, Mutinelli F 4
More informationThe All Wales Medicine Strategy Group (AWMSG) is asked to support implementation of the following prescribing indicators.
ENCLOSURE 5 APPENDIX 1 Paper presented to AWMSG in June 2006 AWPAG considered comments recorded in AWMSG minutes in July 2006 Paper subsequently updated and brought back to AWMSG for endorsement This paper
More informationHospital Burden and Gastrointestinal Surgery in Inflammatory Bowel Disease Patients in Italy: A Retrospective Observational Study
Journal of Crohn's and Colitis, 2015, 853 862 doi:10.1093/ecco-jcc/jjv104 Advanced Access publication June 11, 2015 Original Article Original Article Hospital Burden and Gastrointestinal Surgery in Inflammatory
More informationAUDIT SYSTEM ON QUALITY OF BREAST CANCER DIAGNOSIS AND TREATMENT (QT)
AUDIT SYSTEM ON QUALITY OF BREAST CANCER DIAGNOSIS AND TREATMENT (QT) Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationCosting report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
More informationQStatin Update Information
QStatin -2014 Update Information Revision History Revision date Document Version Summary of Changes 19.08.2014 V1.0 First issue. Contents 1 Purpose of document... 3 2 Rationale for regular updates of QStatin...
More informationNon-commercial use only
Thalassemia Reports 2014; volume 4:4875 Multidisciplinary care in haemoglobinopathies Adriana Ceci, 1,2 Laura Mangiarini, 1 Fedele Bonifazi, 2 Rossella Conte, 2 on behalf of the HTA-THAL Multiregional
More informationDesign, development and first validation of a transcoding system from ICD-9-CM to ICD-10 in the IT.DRG Italian project
Digital Healthcare Empowering Europeans R. Cornet et al. (Eds.) 2015 European Federation for Medical Informatics (EFMI). This article is published online with Open Access by IOS Press and distributed under
More informationCoronary Heart Disease
Coronary Heart Disease This document is a final specification of the PRIMIS Comparative Analysis Service (CAS) MIQUEST query set to enable analyses in support of the NSF for CHD. The specification has
More informationarxiv: v1 [cs.cy] 31 Jul 2015
arxiv:1507.08863v1 [cs.cy] 31 Jul 2015 Keeping up with the e-joneses: Do online social networks raise social comparisons? Fabio Sabatini and Francesco Sarracino August 3, 2015 Abstract Online social networks
More informationTrends for Influenza-related Deaths during Pandemic and Epidemic Seasons, Italy,
RESEARCH Trends for Influenza-related Deaths during Pandemic and Epidemic Seasons, Italy, 1969 2001 Caterina Rizzo,* Antonino Bella,* Cécile Viboud, Lone Simonsen, Mark A. Miller, Maria Cristina Rota,*
More informationRome Date submitted to OIE 21/07/2017
Follow-up report No.16 Report reference:, Reference OIE : 24377, Report Date : 21/07/2017, Country : Italy Report Summary Name of sender of the report Prof. Dr. Romano Marabelli Telephone +390659946945(6)
More informationSurvey of Italian General Practitioners: Knowledge, Opinions, and Activities of Palliative Care
Vol. 46 No. 3 September 2013 Journal of Pain and Symptom Management 335 Original Article Survey of Italian General Practitioners: Knowledge, Opinions, and Activities of Palliative Care Monica Beccaro,
More informationTrends in Pneumonia and Influenza Morbidity and Mortality
Trends in Pneumonia and Influenza Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division November 2015 Page intentionally left blank Introduction
More informationPhysical comorbidity with bipolar disorder: lessons from UK data
Physical comorbidity with bipolar disorder: lessons from UK data Daniel Smith Symposium 33: Big data and bipolar disorder in the UK A failure of social policy and health promotion, illness prevention and
More informationDRG 183 AND 184: ANALYSIS ON THE APPROPRIATNESS OF HOSPITAL ADMISSIONS ACCORDING TO PROTOCOL PRUO. A LOCAL EXPERIENCE
CASEMIX Quarterly, Volume 1 Number 4, 31st December 1999 DRG 183 AND 184: ANALYSIS ON THE APPROPRIATNESS OF HOSPITAL ADMISSIONS ACCORDING TO PROTOCOL PRUO. A LOCAL EXPERIENCE Cinthia Manganaro, Erika Sampognaro,
More informationCounty of Sacramento. Review of Population Health through Kaiser Permanente Data
County of Sacramento Review of Population Health through Kaiser Permanente Data Dr. Diane Dailey, M.D., Chief of Business Health Engagement Eileen Peterson, MPH, RD, TPMG Business Health Consultant, Public
More informationOverweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes
Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes Gordon L Jensen, MD, PhD Senior Associate Dean for Research Professor of Medicine and Nutrition Objectives Health outcomes
More informationWNV, Italian approach. Simonetta Pupella
WNV, Italian approach Simonetta Pupella I, the undersigned speaker, declare that in carrying out the function stated above at this event, I do not have any personal or third-party commercial interests,
More informationPaolo Giorgi Rossi. Consensus Conference : Definzione del percorso di Screening del Cervico-Carcinoma nelle donne vaccinate contro l HPV
(CIN3) and cancers due to HPV 16 and 18 in Italy: Estimating the number of non-preventable cancer in different scenarios of age for starting screening in vaccinated women Paolo Giorgi Rossi Rationale Cervical
More informationChildhood vaccine coverage in Italy after the new law on mandatory immunization
Ann Ig 2018; 30 (Suppl. 1): 1-10 doi:10.7416/ai.2018.2227 Childhood vaccine coverage in Italy after the new law on mandatory immunization C. Signorelli 1,2, A. Odone 2, P. Cella 1, S. Iannazzo 3 Key words:
More informationComments from AstraZeneca UK Ltd
13 June 2007 NICE HTA: Ezetimibe for the treatment of primary (heterozygous familial and nonfamilial) hypercholesterolemia Appraisal Consultation Document (ACD) Many thanks for providing the ACD for the
More informationHCV disease: treatment or deferral? Antonio Craxì Gastroenterologia & Epatologia, Di.Bi.M.I.S., Università di Palermo
HCV disease: treatment or deferral? Antonio Craxì Gastroenterologia & Epatologia, Di.Bi.M.I.S., Università di Palermo antonio.craxi@unipa.it Key factors in deciding to treat or wait Patient factors Urgency
More informationWEST NILE DISEASE IN ITALY
Epidemiological bulletin 2011 WEST NILE DISEASE IN ITALY Introduction 2 Epidemiological situation - in humans - 3 Equids Surveillance 7 Surveillance of resident and wild birds 9 Epidemiological situation
More informationTitle: Hospitalization rates and cost in severe or complicated obesity: An Italian cohort study.
Author's response to reviews Title: Hospitalization rates and cost in severe or complicated obesity: An Italian cohort study. Authors: Enrica Migliore (enrica.migliore@cpo.it) Eva Pagano (eva.pagano@cpo.it)
More informationSetting The setting was primary care. The economic study was carried out in the UK.
Cost-effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK Davies A, Hutton J, O'Donnell J, Kingslake S Record Status This is
More informationThe CINDI Health Monitor Survey. Health behaviour among the Italian adult population,
The CINDI Health Monitor Survey. Health behaviour among the Italian adult population, 2001-2002 Maria Teresa Tenconi 1, Annamaria Gianti 1, Giorgio Pretti 1, Vincenzo Capuano 1, Ada Dormi 3, Simona Giampaoli
More informationHyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine
Hyperlipidemia in an Otherwise Healthy Theodore D Fraker, Jr, MD Professor of Medicine Orlando, Florida October 7-9, 2011 80-Year-Old Patient Primary Prevention Issues in the Elderly: Coronary artery disease
More informationPublic attitudes toward stuttering in Europe: within country and betweencountry
Public attitudes toward stuttering in Europe: within country and betweencountry comparisons Article Accepted Version Creative Commons: Attribution Noncommercial No Derivative Works 4.0 St Louis, K. O.,
More informationObesity and mortality
Obesity and mortality Sam Gutterman, FSA, FCAS, CERA, MAAA, HonFIA INTERNATIONAL MORTALITY AND LONGEVITY SYMPOSIUM 2014 15-17 September 2014, Birmingham Agenda Obesity where are we now Mortality how bad
More informationMethodological approach to measure drug trafficking-related IFFs
Methodological approach to measure drug trafficking-related IFFs Federico Sallusti National Accounts Istat Consultant UNODC Introduction This work presents a set of guidelines to measure illicit financial
More informationRegression Discontinuity Designs: An Approach to Causal Inference Using Observational Data
Regression Discontinuity Designs: An Approach to Causal Inference Using Observational Data Aidan O Keeffe Department of Statistical Science University College London 18th September 2014 Aidan O Keeffe
More informationObservations on US CVD Prevention Guidelines. Donald M. Lloyd-Jones, MD ScM FACC FAHA
Observations on US CVD Prevention Guidelines Donald M. Lloyd-Jones, MD ScM FACC FAHA What are Guidelines? Evidence Base for Guidelines Tricoci, JAMA 2009 Evidence Base for Guidelines Tricoci, JAMA 2009
More informationUpdate on New RCHC Relevant and BridgeIT Reports. Redwood Community Health Coalition Data Group Webinar November 13, 2018 By Ben Fouts, Data Analyst
Update on New RCHC Relevant and BridgeIT Reports Redwood Community Health Coalition Data Group Webinar November 13, 2018 By Ben Fouts, Data Analyst Agenda New Measures (2019) UDS: CAD QIP: Asthma Medication
More informationDeterminants of the drug utilization profile in the paediatric population in Italy s Lombardy Region
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2009.03380.x Determinants of the drug utilization profile in the paediatric population in Italy s Lombardy Region Antonio Clavenna, 1 Marco
More informationNHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021
NHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021 1. Purpose The purpose of this document is to describe both the estimated resource implications to NHS England
More informationMinistry of Health DEPARTMENT FOR ANIMAL PUBLIC HEALTH, NUTRITION AND FOOD SAFETY WEST NILE DISEASE EPIDEMIOLOGICAL SITUATION IN ITALY
Ministry of Health DEPARTMENT FOR ANIMAL PUBLIC HEALTH, NUTRITION AND FOOD SAFETY WEST NILE DISEASE EPIDEMIOLOGICAL SITUATION IN ITALY West Nile Disease in Italy 1998 outbreaks Ministerial decree November,
More informationSUNFRAIL PROJECT Understanding and Caring for Frailty and Multimorbidity. Speaker/Conference/Date
SUNFRAIL PROJECT Understanding and Caring for Frailty and Multimorbidity Speaker/Conference/Date ACKNOWLEDGEMENT This presentation is part of SUNFRAIL (project 664291), which has received funding from
More informationThe Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine
The Heart of a Woman Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine American Heart Association Women, Heart Disease and Stroke
More information